SCHEMBL25049211

SCHEMBL25049211

COc1ccc(C2CCC(n3ccc4c(Cl)nc(Cl)nc43)C2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPBWR1 P48145 1/20 0.35
▸ MCHR1 Q99705 1/20 0.35
▸ SLC6A4 P31645 5/20 0.35
▸ SLC6A3 Q01959 5/20 0.35
▸ SLC6A2 P23975 4/20 0.35
▸ ADRA1A P35348 1/20 0.34
▸ HTR2A P28223 1/20 0.34
▸ GRM2 Q14416 1/20 0.34
▸ PIP4K2A P48426 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ DRD2 P14416 1/20 0.33
▸ CHRNA1 P02708 1/20 0.32
▸ CHRNG P07510 1/20 0.32
▸ ITGA5 P08648 1/20 0.32
▸ CHRNB1 P11230 1/20 0.32
▸ CHRNB2 P17787 1/20 0.32
▸ CHRNB4 P30926 1/20 0.32
▸ CHRNA3 P32297 1/20 0.32
▸ CHRNA4 P43681 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25048803 0.90 PIP4K2A (0.35) ADRA1APIP4K2A
SCHEMBL25046781 0.89 CHKA (0.38) NPBWR1MCHR1SLC6A4SLC6A3SLC6A2
SCHEMBL25046765 0.87 ADRA1A (0.40) ADRA1AHTR2AGRM2MAPTDRD2
SCHEMBL25048741 0.85 OPRM1 (0.38) ADRA1ASMN1; SMN2
SCHEMBL25046755 0.80 PDE10A (0.32) CHRNB2CHRNA4
SCHEMBL25048347 0.79 PIP4K2A (0.33) PIP4K2A
SCHEMBL25048095 0.78 PARP1 (0.32) —
SCHEMBL2173172 0.78 LRRK2 (0.36) PIP4K2A
SCHEMBL25049292 0.77 MCHR1 (0.35) MCHR1
SCHEMBL25049257 0.75 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023017152-A1 SPECIFIC SMALL MOLECULE INHIBITORS THAT BLOCK KMT9 METHYLTRANSFERASE ACTIVITY AND FUNCTION ALBERT-LUDWIGS-UNIVERSITÄT FREIBURG (DE) 2023-02-16 — — WO disclosed
Send feedback